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The expression of the c-mye, c-fas, e-jlm, e-erbB, and e-Ha-ras 
protooncoge nes was compared by Northern bloc analysis of 
total RNA extracted from keratome biopsies of normal skin 
and psoriatic plaques. Isolation of intact RNA from frozen 
tissue required careful attention to technique during the early 
stages of extraction. Densitometric analysis revealed 1.5- to 
2.5-fold elevations of (- IIIye transcript levels in lesional psor-
iatic relative to normal epidermis. Similar increases in cyclo-
philin and lipocortin II transcripts were also observed and 
may reflect characteristic differences in RNA preparations 
from normal and psoriatic epidermis. C-mye, c-jlm, c-erbB, 
c-fos, and c-Ha-ras transcript levels were not significantly in-
P rotooncogel1cs are highly conscrvcd cellular genes, ini-tially discovered by virtue of thei r incorporation into oncogenic retroviruses [1 J. Protooncogenes participate in the regulation of cellular proliferation and differen-tiation at three levels: 1) the interaction of extracellular 
ligands with their cell membrane receptors {e.g., c-cis identified as 
the PDG FI B chain, c-erbB as the EGF recepror, and (-fill S as the 
CSF-1 receptor I2,3]); 2) the transduction of these interactions into 
intracellular biochemical ch:mges (e.g .. [-Ha-rtJs involvemcor in 
GTP metabolism [4] and the activation of phospholipase C by re-
ceptor tyrosine kinases [5]); and 3) the induction of nuclear tran-
scriptional events in response to cytoplas mic signals (e.g., interac-
tion of [{os and (-jil t! to function as DNA-binding transcription 
factOrs 161) . These processes result in changes in cellular differentia-
tion and proliferation which appear to involve (-los [71 and (-my' [8] . 
Psoriasis is a benign, inflammatory skin disease marked by promi-
nent epidermal hyperplasia f9] and a disordered pattern of cel lular 
differentiation [1 OJ. W e have recently demonstrated that trans-
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CSF-t : colony stimulati ng facwr-I 
EG F: epidermal growth factor 
GTP: guanosine triphosphate 
PDGF: platdeHlerived growth factor 
RNA: ribonucleic acid 
SSe: saline sod ium citrate 
TGF-o:: transforming growth facfor-a 
creased in lesional psoriatic epidermis when protooncogene 
mRNA levels were normalized to those of the cyclophilin or 
lipoconin genes. In contrast, transforming growth factor-a 
(TGF-a) transcripts were significantly increased (10- to 20-
fold) with or without prior normalization. C-ffl)'C, c-fos, and 
c-jllt! transcripts were significantly induced over in vivo levels 
2-4 h after organ culmre of normal or psoriatic keratome 
biopsies, demonstrating that these genes can be highly ex-
pressed in the context of tissue injury. OUf results suggest 
that overexpression of these protooncogenes per se is not 
central to the pathogenesis of psoriatic epidermal hyperpla-
sia.] [llvesl DermatoI94:19 -25, 1990 
formin g growth factor-a (TGF-a) is significantly overexpressed in 
psoriatic epidermis [11 J. The cellular receptor for TGF-a, the epi-
dermal growth factor (EGF) receptor, is encoded by the protoonco-
gene c-erbB [3] and has been shown to persist abnormally in the 
supra basal layers of psoriatic epidermis l12]. While overexpression 
of the (-my' [13]. N-my' [14], c-<ebB [13], and ncu/c-erb2 [1 5] pro-
cooncogenes has been shown to correlate with poor prognosis in 
human cancers, the role of protoollcogene overexpression in the 
lll~intcn:1nce of nonmalignant neoplastic prolifcf:l.tion remains 
poorly defined. Therefore, we wished to determine whether in-
creased protooncogene expression accompanies the epidermal hy-
pcrproliferation characterisric of psoriasis. 
Toaccomplish this, we extracted total cel lular RNA from !lonnal 
and lesional psoriatic skin under denaturing conditions and ana-
lyzed ,hese RNA by blot hyb,idization [16]. Taking advantage of 
the re-usability of the blots, we compared the expression of (-£rbB, 
c-Ha-ras, [-my(, ({os, and C-jIW , representing each class of protoonco-
genes (cell surface recepror, signal transduction, and intranuclear) in 
normal skin and psori:aic lesions. Our results indicate that signifi-
cant ovcrcxpress ion of these protooncogenes does not accompany 
psoriatic epidermal hyperplasia. In add.ition, these studies have pro-
vided useful information concerning isolation of intact RNA from 
human epidermis. 
MATERIALS AND METHODS 
Skin Biopsies Aftcrobtaining informed consenc, epidennal kera-
rome biopsies were obtained from rhe buttocks region of patients 
with chronic plaque psoriasis or from heal thy non psoriatic controls 
as p,eviously described [t 7J. 
RNA Isolation and Analysis Immediately upon removal. kera-
tome strips were immersed in liquid nitrogen and scored at -70°C 
until usc. Keratome strips were finel y pulverized in liquid nitrogen 
using it mortar and pestle (see Results). The slurry of pulverized 
fragments in liquid nitrogen was quickly transferred to RNA ex-
traction buffer [4M guanidinium isothiocyanate, 5 mM sodium ci-
trate, pH 7.0, 100 mM 2-mercaptoethanol. 0.5% Sarkosyl, 0.15% 
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Antifoam A (Sigma). 10-60 ml buffer/g wet weighttissueJ. result-
ing in the freezing of the extraction buffer. The frozen extraction 
buffer was immediately homogenized for 30-60 sec using a Poly-
rron homogenizer (Brinkmann). The remainder of the RNA ex-
rranion was perfonned exactly as described [18J. Yields were ap-
proxllnately t Ilg RNAJmg wet weight tissue from both normal 
and p!.oriatic samples. RNA concentration was determined by ab-
sorbance at 260 nm. RNA concentration and intactness were ven-
fied by nondenarunng agarose gel electrophoresis and ethidium 
bromide staining as described (19J. Polyadenylated RNA was pre-
pared by oligo dT-cellulose chromatography [20J. 
Equal quamities of total RNA were size-fractionated by electro-
phoresis in 1% formaldehyde-agarose gels containing 0.5 ,ugJml 
ethidiul11 bromide as described It 8]. After electrophoresis, gels were 
rinsed extensivel y against distilled water and photographed under 
long-wave UV illumination (TL-33, UV Products). Capillary 
transfer of RNA to positi vely-charged derivatized nylon membrane 
(Zeta-probe. Bio-Rad) was then performed in to X saline-sodium 
citrate buffer (SSC; I X SSC = 0.15 M sodium chloride. 0.015 M 
sodium citrate). Hybridizations and washings were performed 
under stringent conditions as described (2 t). Autoradiograms of 
Northern blots were obtained using intensified screens (Cronex, Du 
Pont) and quantitated by scanning the relevam RNA bJnds with a 
laser densitometer (LKll), Blots were stripped for re-hybridization 
by boiling rwice for 20 min in O. t X sse, 0.5% sodium dodecyl 
sulfate. 
Hybridization Probcs Hybridization probes were prepared by 
random priming [221 of the following restriction fragmenrs, which 
were separated from vector fragments by electrophoresis in low-
melting-temperature agarose (BRL,Dethesda. MD): a 414-base-pair 
(bp) Pst I fragment derived from the second non of the c-myc gene 
[23J; a 372-bp Pst I fragment derived from the first exon of the 
c-Ha-ras gene isolated from the E) bladder carcinoma [241; a 3,400-
bp genomic Xho I-Ncol fragment spanning the first three and part 
of the fourth exon or the human r-fos gene [251 or a 528-bp Scul-
Accl genomic fragment spanning the 3' end of the ({os coding 
sequence: a 1.4-kb HindIIl-EcoRl insert containing human C-jlOl 
cDNA [26J; :I. 6-kb EcoRI insert containing human EGF receptor 
(-<,hB) eDNA [27J; a 0.7-kb Eco RI insert containing humanlipo-
cortin II cDNA [28J: and a I .O-kb BamHI insert cOlltaining cyclo-
philin eDNA [29J. 
Organ Culturc Keratome biopsy strips were Cll[ into I.s-cm 
squares immediately after removal and were either frozen immedi-
ately in liquid nitrogen or transported on ice (Q the laboratory 
within 15 mm. Fragments were then placed in Keratinocyte Basal 
Medium {Clone tics) at 37"C in a 5% CO2 incubator. After 2-4 h, 
biopsy fragments were frozen in liquid nitrogen and processed for 
RNA i!tolation as above. 
Data Analysis When appropriate, integrated auto radiographic 
intensities obtained by densitometry were normalized to one of twO 
control genes, lipocortin 11 or cyclophilin, by dividing the intensity 
obtained for the test gene by that of the control gene. Expression in 
psoriatic relative to normal epidermis was obtained by dividing the 
valuelJ obtained for each psoriatic patient by the mean value ob-
tained for the normal group. Statistical analysis was by Student t test 
using a two-tailed hypothesis. Error bars represent SEM. 
RESULTS 
Isolation o[ Intact RNA Figure t depicts the effect of different 
extraction techniques on intactness of RN A extracted from frozen 
or freshly-harvested keratome biopsies of normal human epidermis. 
In Fig lA, loul's a and b, snap-frozen tissue samples tbat were stored 
at -70· C were placed directly in RNA extraction buffer and ho-
mogenization began within IS sec. Note the extensive RNA degra-
dation, especially in la"r b. Lones c-{ contain RNA extracted from 
frozen biopsies pulverized in liquid nitrogen prior to addi tion of 
RNA extraction buffer. The samples shown in lottes c and J were 
allowed fO stand for 30 sec after thawing of RNA extraction buffer 
(Sce Materials alld Methods) before beginning homogenization, 
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whilc those in la'les c and I were homogenized immediately after 
freezing the extraction buffer by addition of pulverized tissue frag-
ments in liquid nitrogen. In contrast, extensive RNA degradation 
was not encountered when freshly-removed, non-frozen tissue was 
dIrectly homogenized. (Figure IB,/anes a-I represent independent 
isolations.) Moreover, tissue fragments placed in organ culture for 
up to 4 h showed no appreciable RNA degradation, as judged by 
RNA Yields and intactness of ribosomal RNA bands (Fig le.D). 
Comparison of Transcript Levels in Normal and Psoriatic 
Epidermis We chose to analyze rotal rather than polyadenylated 
RNA in order to more easily compare large numbers of samples. 
Therefore, it was necessary to demomrratc that normal and psoriatic 
epidermis do not differ in terms of the percentage of total polyade-
nylatcd RNA. Polyadenylated RNA was prepared from normal 
(n = 4) and lesional psoriatic (n = 4) epidermis by oligo-edT) cellu-
lose chromatography and quantitated by absorbance at 260 11m. The 
normal group yidded 2.55% ± 0.48%, and rhe psoriatic group 
yielded 2.70% ± 0.58% polyadenylated RNA (mean ± SD). and 
no sigt1lficant difference was found between the groups (p > 0.10). 
Figure 2 dIsplays the results of RNA blot hybridization experi-
ments comparing the levels of c-myc and (-Ha-ra1 protooncogenc 
transcripts in normal and leslonal psoriatic epidermis, The pattern 
of ethidiul11 bromide staining is shown in Fig 2A. Some degradation 
of two of the normal sal11ples (solid arrars, Fig 2A) is evidenced by 
increased migration of the 285 RNA band. 
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Figure 1. Effects of ~xtr:l.c tlon conditions on RNA IIlUctneS5. RNA s.am-
pb (I JIg) isol:l.ted from ker:l.tome biopsies of norm.1 epidermis under var-
lOllS conditions were subjected todecfrophorc:sis through:l. 1 %~g:l.rose gd ~ 
descnlxd 1191. Mobilities of28 ~nd 18S nbosomal RNA arc Indic~tcd to the 
lift· A) frozen blOpsu:s: IQtlt'5 Q and b, pulverlzalion of frozen ker:uome strips 
Wll onllned, .and homogenization began wllhin 15 sec of Jlddinon of tissue 
to eXlraction buffer. Lam'.s t and J, frozen keratome strips were pulverized 
wlth;l mort;ar ;and pestle III liqUId nitrogen. then added to extr.action buITer. 
Ilomogenlz:uion began 30 sec ~fter thawing of homogel1lution buffer. 
lAllrs rand j. same condillons as lants ( and J except that homogellization 
began Inunediatt'I)' after the extr.acuon buffer was frozen by addmon of 
pulvt'rized tISsue fragments In liquid nitrogen. B) freshly-removed biopsies: 
IQtl n 'IJ. RNA isol.ated from SIX mdependent keratome biopsies Immedi-
:udy aft~r tissue removal without frc('zlng or liqUid IUtTOgen pulvcrizarton. 
C) and D) organ culture: biopsy fr;agmencs wcre euh('r rrozen immediately 
aftcr rcmovalll1 liqUid nitrogen (Iallt a) , after (ransport of a fresh biopsy to 
Ille laboratory on ICC (I/Jlli' b) , or aflcr Incubatlon:lt 37 ·C for 2 h (lat/esc, d) or 
4 h (Jall(,U,j), 35 described ill [he text. SoImpleHilown In laller, J C, .and lan~ 
b, JD were pre~umably degraded dUring processing, 
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Figure 2. RNA blot hybridiZ:lllon to protooncogene transcripts. Northern 
blots of toul RNA (50 JIg) extracted from normal (Itft) and leslonal psoriatic 
(ri~/lt) keratome biopsies were pn:parcd and hybridized 10 variOus probes as 
described 111 Mtllt'riafs aPld Mtthods. Mobilities of 18 and 28S ribosomal RNA 
are mdlcated to the ftjt. A) long.wave UV illumination of ethldium bro-
mide-sl ;uned gels, Solid arrows indicate samples displaying a limited degree of 
RMA degr.adation. 11) hyhridlzation of Northern blot of ge l shown In Fig 2A 
against the C.my( probe, C) r('hybndlution of the blot shown in Fig 28 
agamst the C-Ha-ras probe. D) rehybridlzatloll against tlte lipocorwl II 
prohe. E) hybridization of a different blot (eight normals. ('ighl psoriatics) 
agalTlst the 3.4 kb (-{os probe. In B-E. the mobility of the relevant RNA 
transcnpt as defined by srudies ill other tissues is indicated by the solid arn/WS, 
and add ltlo tu.! bands (sec lext) are indicated by optl1 arrows. 
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Rehybridizatiom of the blot prepared from th is gcl against e-myel {-HtJ-ras, and Iipocorttn II probes are shown in Fig 28- D, respec-
tively. Lipocortin II was chosen as a potential reference gene (or 
internal standard) because it is highly expressed in cultured human 
keratinocytcs and epidermis [30]. In each case. a transcript of the 
predicted size (e-mye. 2.4 kb; c-Ha-rtJs, 1.4 - 1.6 kb; Iipocortin n, 
1.6 kb) was obtained (solid tJrrows) , The faint upper band seen in Fig 
2B (opt" arrolll) probably represents cross-hybridization to the 28 S 
ribosomal RNA . as it is absent in blots prepared from psoriatic 
polyadenylated RNA (data not shown). In addition to the band at 
1.4 kb, the c-Ha·ras probe also detected two bands migrating at 
approximately 2.6 and 5,0 kb in Fig 2C (ope,. arrows, see Disw ssion) . 
Figure 2E depicts rhe result of a different experiment comparing 
hybridization of total RNA from normal or lesional psoriatic epi-
dermis to the (-{os probe. Using the 3.4-kb Xhol-Ncol probe, hy-
bridization to tIl e 2.2 kb ,-fox mRNA (closed tJrrow) was faint. and 
cross-hybrid ization to rhe region of the blot containing 28S ribo-
somal RNA was evident (Opell arrow). Rchybridization of the blot 
used in Fig 2A -Cagainst the 3.4 kb c-fos probe is nor shown because 
of an unacceptably high background hybridization. 
The band intensities of the e-mye and c-Ha-ras transcripts appeared 
to be moderately increased in psoriatic lesions; however, hybridiza-
tion to the lipocortin II reference probe also appeared to be similarly 
increased. Moreover. the variation in band intensities from sample 
to sample was similar for all three probes, suggesting that increased 
hybridization to protooncogene probes in the psoriatic samples 
might refl ect differences in the quality and/or nature of RNA prep-
:uatio ns obtained from normal and psoriatic skin . Therefore. we 
repeated the experiment with RN A samples from different patients 
and selected a different reference probe, cyclophilin. This probe has 
been shown to be expressed at high levels in a variety of tissues r29]. 
and levels of cydophilin protein are nOt significantly different in 
normal and psoriatic epidermis [3 1}, The results of these studies are 
shown in Fig 3. 
The blot shown in Fig 3A was hybridized with a mixture of c-mye 
and cyclophil in probes and again demollStldtes an increase in the 
2.4-kb c-my{ ttallScript in psoriatic lesions. However, a similar in-
crease in the 1.0-kb cydophil in mRNA was also noted and is more 
apparent on a lig hter exposure of the autoradiogram (Fig 3A, lower 
p(Hlll). A dupl icate blot was prepared and hybridized to a mixture of 
cyclophilin probe and the 528-bp Stul-Accl ({os 3' end probe. os 
shown in Fig 3B, Note that 2 of the no rmal samples display high 
levels of c-Ios transcripts. and that the signal-to-noise ratio using the 
3' end probe is improved relative to that obtained with the 3.4-kb 
Xba-Ncol probe used in the ex:reriments shown in Fig 2. 
These blots were stripped an rehybridized to the {-jIUl, c-Ha-ras, 
and r-erbB protooncogene probes. as shown in Figs 3C-E. Each 
probe detected transcripts of the expected sizes {e-jml, 2.7 kb {26J; 
(-<rbB. 12.6. and 2_5 kb [27])_ Other bands were also observed (sec 
DiSCImio tl) . For comparison. rchybridization of one o f these blots to 
the T GF-O' probe [I I] is shown in Fig 3F_ 
The signal intensities of rnRNA bands detected by the c-my{ 
(2.4 kb). (-Ha-ras (1.6 kb). ({os (2 _2 kb). (-jllll (2 _7 kb). c-erbB 
(2.5 kb). cyclophilin (1.0 kb) . lipocortin II (1.6 kb) . and TGF-a 
(4.8 kb) probes show n in Figs 2 and 3 were quantitated by laser 
densitometry, and the results are summarized in Fig 4. Only the 
increase or decrease of intensity in psoriatic lesions relative to the 
mean value obtained for normal epide rmis is shown. In addition, the 
data arc compared either as raw integrated optical densities (black 
bars) or after normalization to either lipocortin 11 or cyclophilin 
(haulted bars) . C-myc mRNA levels were significantly (p.s ,05) in-
creased (approximatley twofold) in psoriatic lesions when the raw 
intensities were compared. However. similar significant increases 
were observed for lipocortin II and cyclophilin transcripts, and all 
significant diffe rences in protooncogene expression were lost after 
normalizing the data to either lipocortin II or cyclophilin (hatched 
bars) . In contrast. expression ofTG F-a transcripts remains signifi-
can tl y and highl y signifi cantly elevated in lesional epidermis with 
or withom prior nOfmalization. 
Protooncogcne Express io n in O rgan C ulture In order to test 
the hypothesis that protein kinase C is down-regulated in psoriatic 
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Figure 3. RNA blot hybridiution o ( protooncogene transcripts (upcrullent 2). Shown to the lift arc 18 and 28S nbosomal RNA markers. -cy denotes 
locanon of cyclophliin transcripts. SoUd arrow! indicate transcnpts of prevlou.dy-reported sizes. Optn arrows indIcate cross-hybridizatIon to 285 RNA. 
lesions 1321. we wished to compare the responses of normal and 
psoriatic keratome biopsies to phorbol ester treatment in organ cul -
ture. However. in pilot experiments, we found that large inductions 
of several protooncogene transcripts occurred in the absence of 
phorbol ester treatment. The resules of these experiments arc shown 
in Fig 5 and quantitated in Table I. C-my{, (-fos, and (-j.m was 
induced from rwofold co greater than ISO-fold after 2-4 It of organ 
culture. while (-Ha-ras, TGF-a. and cyclophilin were not induced 
« 1.5-fold). 
DISCUSSION 
Using the Northern blotting technique, we have demonstrated ex-
pression of the (-mye, (- Ha-ras, (-f05, (-jim, and c-erbB prOrOaDCD-
genes in normal and psoriatic ski n. We found that careful attention 
co technique was necessary during the early stages of the extraction 
procedure in order to ensure the isolation of intact RNA (Fig lA). 
This is not surrrising, because ribonuclcases arc abundant in human 
epidermis [33 . We also found that the process of freezing and 
rhawing increases the degradation encouncered during isolation of 
epidermal RNA . This could be due to disruption of cellular organ-
elles and membranes, causing increased access of enzyme to sub-
strate during the early stages of isolation . This interpretation is 
consistent with the observed stabi lity of epidermal RNA in fresh 
biopsies (Fig I B) and in epidermal organ culwres for up to 4 h (Fig 
le,D). 
These observations suggest that modest differences in mRNA 
transcript levels in normal and psoriatic skin analyzed by these 
methods should be interpreted cautiously. We have consistently 
found an approximately twofold increase in (-my' mRNA in psoria-
tic lesIOns; however, these differences have been paralleled by those 
of two putative references genes. Iipocortin II and cyclophilin. In 
contrast, TGF-a mRNA is consisrcnciy and signifia.ndy increased 
in psoriatic lesions [11] to a much greater extent than either refer-
ence gene. The other protooncogenes rested were not consistendy 
increased in psoriatic lesions. and ,-jos transcript levels appear to be 
slightly decreased in psoriatic lesions (Figs 38, 4). 
The presence of additional hybridizing bands in our studies can 
usually be explained by non-specific hybridization to the large 
amounts 0£28S ribosomal RNA prescm in our preparations. How-
ever, in rhe case of (-Ha-ras, a 2.6-kh transcript has been observed by 
ourselves and by Ogiso et ai, who have suggested that it is due to 
hybrid izarion (0 Ki-ras transcripts [34J. 
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Figure ... Quamitation of protooncogene transcripts in normal and lesional 
psori:nic epidermis. The bands indicated by the solid a"ol"s in Figs 2 :li nd 3 
were quantitated by laser densitometry and expressed as fold-change rdative 
to normal epidermis as described in Matt!ria/s arid Mrthods. Solid bars: r.lW 
integrated autorad iographic intensities: hauhtd bars; integrated :mtoradio-
graph ic intcnllitics normalized to lipocortin II (experiment \ ) or cyclophilin 
(experiment 2) as described in Materials and Mt thods; dashtd line: mean levels 
obtained III normal epidermis. 
Mordovtsev and co-workers have compared the expression of 
severalprotooncogenes in normal psoriatic skin by RNA dot blot-
ting [351. While this technique is insensitive to RNA degradation, it 
docs not discrimin;ae between signal and background hybridiza-
non. For example. our hybridizations with c-/os (Fig 2£) and Ki-ras 
(not shown) probes have revealed high levels of diffuse background' 
hybridization. Nevertheless, our resules agree that c-myc and c{os 
genes are expressed in psoriatic skin, and c-myc mRNA levels arc 
increased in psoriatic epidermal RNA. However, we did not find 
increased levels of ,-/os mRNA in the psoriatic RNA samples. Also, 
we did not observe the significant variation in epidermal ,-my, ex-
pression nor th e correlation between epidermal ,-my, and '-los cx-
pression reported by Ogiso et al [34]. Variability in tissue sampling 
and in quality of RNA preparations could account for rhe covaria· 
rion of c-myr and ':(05 transcripts observed by these workers. 
Thompson et al {19J have demonstrated that ' -myr expression is 
independent of position in the ce ll cycle in aCtively cycling cells, 
while its expression is greatly reduced or absent in quiescent ("Go") 
cel ls. It is generally agreed that the growth fraction of the germina. 
tive layers of psoriatic epidermis approaches 100%, whereas esti-
mates for normal epidermis range from 10% to 50% {9]' On this 
basis. a greatcr increase in (-my' expression than we have observed in 
psoriatic epidermis might have been expected. Our resul ts suggest 
that c-my( expression may display a more complex relationship to 
cellular growth state in epidermal keratinocytes in vivo than in 
growth-arrested vs actively cycl ing cells in vitro [36]. 
King and co-workers described an altered discribution of EGF 
receptors in psoriatic epidermis [12]. However, they did nOt find a 
signi ficantly increased amount of EGF receptors in psoriatic epi-
dennis Oil a protein or DNA basis [121. This is consistent with our 
findin g that c-erbB transcripts are not increased in psoriatic lesions. 
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In contrast, TGF-a mRNA and protein are significantly incre3sed 
in psoriatic lesions [11]. Because TCF-Q appears to be the endoge-
nous epidermal ligand for the EGF receptor, these results suggest 
that regulation ofTGF-a synthesis is more central to the molecular 
pathogenesis of psoriasis than is regulation of the synthes is of its 
receptor. 
We have observed significant increases in mRNA levels of three 
proto-oncogenes, (-myr. c-/os, and c-j""1 after placing normaJ and 
psoriatic keratome biopsies into organ culture. These observations 
increase our confidence that these genes are expressed at low but 
detcctable levels in normal and psoriatic skin in vivo because our 
probes detcct grea tly increased amounts of the same-sized tran-
scrip ts under our in vi tro conditions. Increased expression of these 
genes occurs upon entry into the ce ll cycle 137}, and antisense inhi-
bition cx£eriments have demonstrared a requitement for c-my' [81 
and c-fos 138] in cell cycle progression. Increased expression of these 
procooncogenes is induced in vitro by phorbol esters, certain growth 
factors, and ultraviolet light, and in vivo by injurious stimuli such as 
tape stripping of the epidermis [39-4 t I. In the latter setting, these 
protooncogenes may participate in the initiation of reparanve epi-
dermal hyperplasia. However, unlike TGF-a, these protoonco-
genes are not overexpressed significantly, if at all , in the steady-state 
hyperplasia that characterizes psoriatic epidermis. It is possible that 
the molecular mechanisms that main tain epidermal hyperplasia in 
psoriasis are different from those that ini tiate it after epidermal 
injury. 
Our results document the expression of several procooncogenes at 
the level of steady-state mRNA in normal and psoriatic human skin. 
The prcsence of the same transcripts, at similar levels, in normal 
epidermis suggests that these genes arc important regulators of epi-
dermal cell proliferation and differentiation in both normal and 
NORMAL 
o 2h 4h 
nilil 
PSORIASIS 
o 2h 4h 
nilll 
c-myc 
c- fos 
c-Jun 
c- Ha-ras 
cyclo 
TG F-cx 
Figure S. Induction of protooncogene transcripts in organ cu lture. Only 
the relevant hybridizing bands are shown. See text for details. 
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Table I. Fold-Change in mRNA Levels in Organ Culture of Normal and Psoriatic Epidermis 
Normal- Psorianc-
Gene 2 hr(n) 4 hr(n) 2 hr(n) 4 hr(n) 
Cyclophilm 1.05(3) 1.17(4) 1.08(4) 0.96(6) 
,-my" 19.90(3) 27.70(4) 1.96(4) 2.47(6) ({os' 7.71(3) 4.42(4) 3.56(4) 6.45(6) 
e-jun' 18.40(3) 18.30(4) 91.50(2) 184.20(3) 
e-Ho-ro~ 0.70(3) 0.76(4) 1.31 (4) 1.35(6) 
TGF-o' 1.13(3) 1.33(4) 0.37(4) 0.72(6) 
• Means of Ihe lI1dlcaled number of umplcs are shown. Values art' rxpreued as fold-change over mean Inlcgnrcd optIcal dClUlty al time zero. 
~ NormalIZed to cycloph llln ' 
psoriatic skin, Future insights il1[o the roles of these protooncogcnes 
in epidermal growth regulation will be gained through the us~ ofin 
situ detection methods for protooncogene mRNA and protem and 
through further exploration of the organ culture model syncm. 
W" tlttmlt Gary FiJlter Jor many htlp/ul diJeWlSionJ Qnd Jor rnli~ o/,It" mQ"uJcrI'p', 
PraslttHIf Tril'tdi and CQroly" Pett'TJon for Jltilled teclt"ieQI tusiJtQnct, and Barbora 
WoUntrojBiogen Corp., Rik iXrynelt ojCtntnttelt, 1m., Pmr Angel ojUnil1wity 
ojCQlijom;Q, LA jollQ, Qnd MQ" HQrdingoJYQlt Unil1rrJityJorgtnerouJ provision oj 
eDNA probtJ, 
REFERENCES 
I. Uishop JM: The molecular genetics of cancer. Science 235:305, 1987 
2. Heldin C H, Westermark 13: Growth factors: Mechanism of acrion and 
relation to oncogenes. Cell 37:9-20, 1984 
3. Vardin V. Ullrich A: Molecular analysis of signal transduction by 
growth factors. Biochemistry 27:31 13-3123.1988 
4. Lowy DR, Willul11sen BM : The rQS gene family. Cancer Surveys 
5:275-289.1986 
5. Wahl MI. Olashaw NE, Nlshlbc S, Rhee SG, Pledger WJ, Carpenter 
G: Platelet-derived growth factor induces rapid and sustained tyro-
Sine phosphorylation of phospholipase C-), in quiesccn! BALB/c 
3T3 cdls. Mol 0:11 Bioi 9:2934 - 2943. 1989 
6. Sassone-Corsi P. Ransone LJ . umph WW. Venna 1M: Dlrec{ interac-
tion between JOJ and 1'14" nuclear oncoproteins: role of thr "leUCine 
zipper" domain. Nature 336:692-695.1988 
7. Man JL: The 10J gene as "master switch." Science 237:854 - 56, 1987 
8. Freytag SO: Enforced expression of the e-my' oncogene mhibus cell 
differentiation by precluding entry iuto a distinct predifferelltiation 
state in GO/G 1 , Mol Cell Bioi 8:1614-1624, 1988 
9. WeillS[CIII GD, McCulloughJL. Ross PA: Cell kinetic basis forpalho-
physiology of psoriasis. J Invest Dcrmatol 85:579- 583, 1985 
10. Uern,ud SA, Assdineau D, Schaffar-Deshayes L, Darmoll MY: Ab-
normal sequence of express-ion of differentiation markers in psoriatic 
epidermiS: Inversion of two steps in the differentiation program. J 
InveSI DermatoI90:801-805, 1988 
II . Elder JT, Fisher GI. Linquist PB, Bennen GL, Pinelkow MR. Coffey 
RJ. Ellingswonh L, Derynck R, Voorhees JJ : Overexpresslon of 
transforming growth faetor-a in psonatic epidermiS. Science 
243:811-814.1989 
12. Nanney LB, Stoschcck CM, Magid M, King LE: Altered (l 25IJepldcr-
mal growth factor blndmg and receptor distnbuflon In psoriaSIS. J 
Invest DermatoI86:260-265, 1986 
13. Yao M. Shum T, Ml.$aki H, Kubota Y: Enhanced expression of c-myr 
and epidermal growth factor receptor (c-f'rbB-I) genes m primary 
human renal cancer. Cancer Res 48:6753-6757. 1988 
14. Grady-Leopardl EF, Schwab M, Ablin AR, Rosenau W: Detecrion of 
N-rnye oncogene rxpresslon In human nruroblastoma by j" Jjtu hy~ 
bridization and blot analysis: relationship to clinical outcome. 
Cancer Res 46:3 196-3 199. 1986 
15. ShImon DJ. Clark GM: Amplification of c-trbll-2 and Olggre5Slve 
hUlIlan brraSt tumors? Scicflce 240:1795-1798,1988 
16. Thomas PS: Hybridization of dcnatured RNA and small DNA frag-
ments mlllsferred to nitrocellulose. Proc Nat! ..... cad Sci USA 
77:5201-5205.1980 
17. Voorhees JJ. Duell EA. Bass LJ. Powell JA. Harrell ER: Decreased 
cyclic AMP 11\ the epidermis of leSions of psoriasis. Arch Dcrm 
105:701.1972 
18. ManiatIS T. Fritsch EF, Sambrook J : Extnctlon. puri6C2tlon. and anal-
ySIs of mRNA from eukaryotic cel ls. In: MoltCulQrCfoning: A LAbora-
tory ManwQI, Chapf 6. Cold Spnng Harbor Laboratory, Cold Spong 
Harbor 1982. pp 188 -209 
19. Thompson CB. Chalionrr PB. Neiman PE, Groudine M: Ltvels of 
c-myc oncogene mRNA are invariant throughout the cell cycle. 
Naturc 314:363-366. 1985 
20. AVIV H, Ltder P: Purification of biologically acrive globin mes~nger 
RNA by chromatography on oligothymidylic acid-cellulose. Proc 
N,II Ae,d Sc; USA 69: 1408 - 1412. 1972 
21. Elder JT, Gupta AK. Fisher GJ, Voorhees )): Cyclosponfle inhibits 
omidline decarboxylase gene expression and acutr inflammation in 
response to phorbol ester treatmcnt of h:mless mouse skin. Trans-
plant Proc 20:95-104,1988 
22. Feinberg APt Vogelsrein B: A technique for ndlolabcling DNA re-
stricrion endonuclease fragments to high sprc,6c activity. Analytic 
Blochem 132:6- 13,1983 
23. Haney J, Moulding C, Taub R, Murphy W, Stewart T, Potier H, 
Lenoir G, Ltder P: The human c-myc oncogenr:: Structural COI1.S(.'-
quellces of translocation Into the IgH locus in Uurkitt lymphoma. 
CdI3079-787.1983 
24. Capon OJ. Chen EY t Lc:vill.$on AD, Seeburg PH, Goeddcl DV: Com-
plete nucleotide sequences ofT24 human bladder carcinoma onco-
gene and Its normal homologue. Nature 302:33-37. 1983 
25. Curran T. MacConnell WP, van Srraaten F, Verma 1M: Structure of 
the FUJ murine osteoSOlrcoma virus genome: Molct:ular cloning of 
ItS associated hdper VI.rtJS and the cellular homolog of the "105 gene 
from mouse human cells. Mol Cell Bioi 1:9 14 -92 1. 1983 
26. Angel P. Allegretto EA, Okmo T, Haton K. Boyle WJ. Hunter T. 
Karin M; Oncogene ju" encod('s a sequence-speci6c trap/s-activator 
Similar 10 AI'-1. Nature 332:166-171, 1988 
27, Xu Y, Ishii S, Clark AJL, Sullivan M, Wilson RK. Ma OJ>, Roc BA, 
Merlino GT, PaStan I: Human epidermal growth factor r('(cptor 
cDNA is homologous to a vanety of RNAs overproduced In A431 
C:llrcinoma cells. Nature 309:806-810,1984 
28. Huang K-S. Wallner UP. ManaJ.ano RJ, Tinrd R. Burne C. Frey A, 
HesSion C. McGray P,Slnclalr LK. Chow EP. UrowningJL. Rama-
chandran KL, TangJ, SmartJE, Prpinsky RB: Two human 35 kd 
inhibitors of phospholipase Al arr rdatrd to 5ubstrates of pp60w-on: 
and of the rpidermal growth factor reccptor/kina~. Cell 46: 191 -
199.1986 
29, Danielson PE, Forss-Pettrr S, Urow MA, Calavrfta L. Douglass J, 
Milner RJ, Sutcliffe JG, pi B15: a cD NA clonr of the rat mRNA 
encoding cyclophilin. DNA 7:261-267,1988 
30, Eldcr JT, Wallner UP, Peplllski RH, Fishrr GJ, Voorhrcs JJ: Charac-
t("nzarion of lipocortin grnr expression 111 human keratlllocytes. J 
Invest Oermatol BB:487, 1987 
31. Griffiths CEM, Fisher GJ. Harding MW, Elder JT. VoorheesJJ: Cy-
c10philin content of nonnal and p~oriatic epldennis, Submitted for 
publication 
VOL. 94. NO. 1 JANUARY 1990 
32. Horn F, Marks F. Fisher GJ. Marcelo Cl. Voorhees JJ: Decre:ued 
protein kinase C activity in psoriatic versus nonnal epidermis. J 
Invest DennatoI88:220 - 222. 1987 
33. Melbye SW, Dram BA. Freedberg 1M: Epidermal nucleases. 111. The 
ribonucleases of human epidennis. Br J Demlatol 97:355. 1977 
34. Ogiso Y, Oikawa T . Kondo N. Kuzumaki N. Sugihara T. Ohura T : 
Expression of proto-oncogenes in normal and rumor tissues of 
human skin. J Invest Dennacol 90:841 - 844, 1988 
35. Mordovtsev VN. Starkey IV. Zabarovsky ER, Kisselev Ll: .Expression 
of the pro{ooncogenes is psoriatic lesions. Arch Dermatol Res 
280:8 - 11,1988 
36. Nepveu A, Lc:vine RA. Dmpisi J. Greenberg ME. ZiffER. Marcu K.B: 
Alternative modes of c-my' regulation in growth factor-stimulated 
and differentiating cells. Oncogene 1:243 - 250. 1987 
37. Ryseck H.-I), Hirai 51, Yaniv M. Bravo R: Transcriptional activation of 
PROTOONCOGENE EXPRESSION IN PSORIASIS 2 5 
c-jut! during the CO/ G' transition in mouse flbroblasts . Nature 334-
535 - 537,1988 
38. Holt JT. Venkat Gopal T. Moulton AD, Nienhuis AW: Inducible 
production of r-fos anrisense RNA inhibits 3T3 cell proliferation. 
P",c Nad Aod Sd USA 8304794-4798,1986 
39, L:!.mph WW, Wamsley p. Sasson~-Corsi p. Verma 1: Induction of 
proro-oncogene jun/ AP-1 by serum and TPA. Nature 334:629-
631 , 1988 
40. Ronai ZA, Okin E. Weinstein 18: Ultraviolet light induces thecxpres-
sion of oncogenes in rat fibroblast and human keratinocyce cells. 
Oncogene 2:201 - 204, 1988 
41. Guacomoni PU: One-gene expression in hyperplasia induced by tape 
stripping or by topical applications ofTPA. Br J Derm 115:128 -
132, 1986 
MEETING ANNOUNCEMENT AND CALL FOR PAPERS 
The Eighth Imernanonal Symposium on Bioengineering and the Skin is CO be held at Stresa. 
Lake Maggiore, Italy on the 13th to the 16th of June 1990. Local OrgaJlizers: G. Rabbiosi, S. 
Sacchi, G. Borroni, E. Berardesca, Department of Dermatology, University of Pavia, 27 100 
Pavia. Italy. Dermatologists, pharmacologists. plastic surgeons. cosmetic chemises, and other 
scientists in the field will guher to discuss technologies and methods for the non-invasive 
evaluation of skin physiology, pathology. therapy. and skin product assessment. Invited 
speakers will present updates on current bioengineering issues. Deadline for abstract submiss ion 
is January 31, 1990. Abstracts shou ld be ryped on A4 paper with 1-il1ch left margin and should 
include title, author's name and affiliation, and a summary not exceeding 300 words. Abstracts 
should be sent to: Dr. Jorgen Serup, Department of Dermatology, Rigshospitalet H 5 132,9 
Hlcgdamsvej, 2100 Copenhagen, Denmark or to: Dr. Randy Wickett, S.C. Johnson & Son, 
1520 Howe Street, Racine WI 53403-5011. 
